KRRO
KRRO
NASDAQ · Biotechnology

Korro Bio Inc

$12.05
-0.84 (-6.52%)
As of May 16, 2:12 AM ET ·
Financial Highlights (FY 2026)
Revenue
8.29M
Net Income
-152,068,374
Gross Margin
44.7%
Profit Margin
-1,834.5%
Rev Growth
-23.1%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 44.7% 44.7% 36.3% 36.3%
Operating Margin -1,906.4% -1,715.7% -18.2% -15.4%
Profit Margin -1,834.5% -1,742.8% -21.6% -18.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 8.29M 10.78M 16.40M 15.17M
Gross Profit 3.71M 4.82M 5.95M 5.50M
Operating Income -158,019,638 -184,986,568 -2,982,822 -2,336,962
Net Income -152,068,374 -178,019,688 -3,544,265 -2,816,245
Gross Margin 44.7% 44.7% 36.3% 36.3%
Operating Margin -1,906.4% -1,715.7% -18.2% -15.4%
Profit Margin -1,834.5% -1,742.8% -21.6% -18.6%
Rev Growth -23.1% -23.1% +19.8% +8.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 18.25M 14.30M
Total Equity 49.68M 50.11M
D/E Ratio 0.37 0.29
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -145,691,069 -180,029,286 -3,398,004 -2,964,187
Free Cash Flow -3,167,900 -2,994,560